Patents by Inventor Roger Gillespie
Roger Gillespie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180195300Abstract: A stud spacer. The stud spacer includes an elongated bar having a first portion and a second portion, wherein the first portion includes at least one channel therein. At least one rod extends perpendicularly away from an interior surface of the second portion and is slidably engaged with the channel such that the second portion can selectively move between an extended position and a retracted position. When the second portion is in the extended position, a linear distance between a first end of the elongated bar and a second end of the elongated bar is greater than when the second portion is in the retracted position. At least one fastener is disposed on a lower side of the elongated bar.Type: ApplicationFiled: January 10, 2018Publication date: July 12, 2018Inventors: Roger Gillespie, Stephen Leadingham
-
Publication number: 20090084328Abstract: A water heater includes a water container, a combustion chamber adjacent the, water container, a burner associated with the combustion chamber and arranged to combust fuel to heat water in the water container, a blower assembly positioned to receive combustion gases generated by the burner, a shield positioned below at least a heating portion of the burner, a diverter that directs combustion air into the combustion chamber below the shield, and a passageway that directs at least a portion of the combustion air from the combustion air inlet, as primary combustion air, to the burner.Type: ApplicationFiled: October 1, 2007Publication date: April 2, 2009Inventors: Jeff L. Lyons, Timothy Smith, Roger A. Gillespie, John L. Dreher, III, Emadeddin Y. Tanbour
-
Publication number: 20080039449Abstract: The present invention relates to novel classes of compounds which are inhibitors of interleukin-1? converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-?-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-?-mediated diseases and decreasing IGIF and IFN-? production using the compounds and compositions of this invention.Type: ApplicationFiled: January 18, 2007Publication date: February 14, 2008Inventors: Mark Batchelor, David Bebbington, Guy Bemis, Wolf Fridman, Roger Gillespie, Julian Golec, David Lauffer, David Livingston, Saroop Matharu, Michael Mullican, Mark Murcko, Robert Murdoch, Robert Zelle
-
Publication number: 20070281936Abstract: Compounds of formula (I); wherein R1 is H or NHZ; R2 is optionally substituted aryl or heteroaryl attached via a carbon atom; R3 is H; optionally substituted C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, or C3 C7 cycloalkyl, halogen; OH or OR, or R4 is H, optionally substituted C1-C6alkyl, C3 C6alkenyl, C3-C6alkynyl, C3-C7 cycloalkyl, aryl or heteroaryl, R5 is H or optionally substituted C1-C6alkyl, C3-C6alkenyl, C3-C6alkynyl, or C3-C7 cycloalkyl; or R4 and R5 together form a 5 or 6-membered heterocyclic ring; and R10 is optionally substituted C1-C6alkyl; are purine receptor, particularly adenosine receptor antagonists, useful for treatment of, inter alia, movement disorders such as Parkinsons disease.Type: ApplicationFiled: February 11, 2005Publication date: December 6, 2007Applicant: Vernalis (R & D ) LimitedInventors: Roger Gillespie, Richard Todd, Gemma Stratton, Allan Jordan
-
Publication number: 20070079771Abstract: A water heater including a water container; a combustion chamber adjacent the water container; a burner associated with the combustion chamber; a blower assembly located to receive combustion products generated by the burner; an intake conduit sealingly connected to the combustion chamber and having a combustion air intake opening located adjacent an upper portion of the water heater; and a dilution air conduit sealingly connected to the blower assembly and having a dilution air intake opening located adjacent a lower portion of the water heater.Type: ApplicationFiled: October 31, 2006Publication date: April 12, 2007Applicant: American Water Heater Company, a corporation of NevadaInventors: Michael Garrabrant, James York, Jeff Lyons, Tim Smith, Roger Gillespie
-
Publication number: 20070049607Abstract: The use of a compound of formula (I): wherein R1 is selected from H, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, halogen, CN, NR5R6, NR4COR5, NR4CONR5R6, NR4CO2R7 and NR4SO2R7; R2 is selected from aryl attached via an unsaturated carbon; R3 is selected from H, alkyl, COR5, CO2R7, CONR5R6, CONR4NR5R6 and SO2R7; R4, R5 and R6 are independently selected from H, alkyl and aryl or where R5 and R6 are in an NR5R6 group, R5 and R6 may be linked to form a heterocyclic group, or where R4, R5 and R6 are in a (CONR4NR5R6) group, R4 and R5 may be linked to form a heterocyclic group; and R7 is selected from alkyl and aryl, or a pharmaceutically acceptable salt thereof or prodrug thereof, in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, particularly wherein said disorder is a movement disorder such as Parkinson's disease or said disorder is depression, cognitive or memory impairmeType: ApplicationFiled: August 22, 2006Publication date: March 1, 2007Inventors: Roger Gillespie, Joanne Lerpiniere, Suneel Gaur, Samantha Bamford, Gemma Stratton, Stefania Leonardi, Scott Weiss
-
Patent number: 7159540Abstract: A water heater including a water container; a combustion chamber adjacent the water container; a burner associated with the combustion chamber; a blower assembly located to receive combustion products generated by the burner; an intake conduit sealingly connected to the combustion chamber and having a combustion air intake opening located adjacent an upper portion of the water heater; and a dilution air conduit sealingly connected to the blower assembly and having a dilution air intake opening located adjacent a lower portion of the water heater.Type: GrantFiled: October 20, 2004Date of Patent: January 9, 2007Assignee: American Water Heater CompanyInventors: Michael Garrabrant, James York, Jeff Lyons, Tim Smith, Roger Gillespie
-
Publication number: 20060270691Abstract: Use of a compound of formula (I) wherein R1 is selected from alkyl, aryl, alkoxy, aryloxy, 0thioalkyl, thioaryl, CN, halo, NR5R6, NR4COR5, NR4CONR5R6, NR4CO2R7 and NR4SO2R7; R2 is selected from N, O or S-containing heteroaryl groups, wherein the heteroaryl group is attached via an unsaturated carbon atom which is adjacent to one or two N, O or S-heteroatom(s), other than ortho, ortho-disubstituted heteroaryl groups; R3 is selected from H, alkyl, COR8, CONR9R10, CONR8NR9R10, CO2R11 and SO2R11; R4, R5 and R6 are independently selected from H, alkyl and aryl or where R5 and R6 are in an (NR5R6) group then R5 and R6 may be linked to form a heterocyclic ring; R7 is selected from alkyl and aryl; R8, R9 and R10 are independently selected from H, alkyl and aryl, or R9 and R10 may be linked to form a heterocyclic ring, or where R8, R9 and R10 are in a (CONR8NR9R10) group, R8 and R9 may be linked to form a heterocyclic group; and R1 is selected from alkyl and aryl, or a pharmaceutically acceptable salt thereof or prodrType: ApplicationFiled: July 19, 2006Publication date: November 30, 2006Inventors: Roger Gillespie, Joanne Lerpiniere, Claire Dawson, Suneel Gaur, Robert Pratt, Gemma Stratton, Scott Weiss
-
Publication number: 20060191497Abstract: A water heater including a water container; a combustion chamber adjacent the water container; a burner associated with the combustion chamber; a blower assembly located to receive combustion products generated by the burner; an intake conduit sealingly connected to the combustion chamber and having a combustion air intake opening located adjacent an upper portion of the water heater; and a dilution air conduit sealingly connected to the blower assembly and having a dilution air intake opening located adjacent a lower portion of the water heater.Type: ApplicationFiled: March 31, 2006Publication date: August 31, 2006Applicant: American Water Heater Company, a corporation of NevadaInventors: Michael Garrabrant, James York, Jeff Lyons, Timothy Smith, Roger Gillespie
-
Publication number: 20060128731Abstract: Use of a compound of the formula (I) wherein R1 is selected from alkyl, alkoxy, aryloxy, alkylthio, arylthio, aryl, halogen, CN, NR7R8, NR6COR7, NR6CO2R9 and NR6SO2R9; R2 is selected from aryl attached via an unsaturated carbon; R3 and R4 are independently selected from H, alkyl, halogen, alkoxy, alkylthio, CN and NR7R8; R5 is selected from H, acyclic alkyl, COR6, CONR7R8, CONR6NR7R8, CO2R9 and SO2R9; R6, R7 and R8 are independently selected from H, alkyl and aryl or where R7 and R8 are in an NR7R8 group R7 and R8 may be linked to form a hererocyclic group, or where R6, R7 and Rs are in a (CONR6NR7Rs) group, R6 and R7 may be linked to form a hererocyclic group; and R9 is selected from alkyl and aryl, or a pharmaceutically acceptable salt thereof or prodrug thereof, in the manufacture of a medicament for the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, particularly wherein said disorderType: ApplicationFiled: January 27, 2006Publication date: June 15, 2006Inventors: Roger Gillespie, Joanne Lerpiniere
-
Publication number: 20060111373Abstract: Use of a compound of formula (I): wherein R1 is selected from alkyl, alkoxy, aryloxy, alkylthio, arylthio, aryl, halogen, CN, NR6R7, NR5COR6, NR5CONR6R7, NR5CO2R8 and NR5SO2R8; R2 is selected from heteroaryl attached via an unsaturated carbon; R3 is selected from H, alkyl, halogen, OR5, SR5 and NR6R7; R4 is selected from H, acyclic alkyl, CONR6R7, CONR5NR6R7, COR6, CO2R8 and SO2R8; R5, R6 and R7 are independently selected from H, alkyl and aryl, or where R6 and R7 are in an NR6R7 group, R6 and R7 may be linked to form a heterocyclic group, or where R5, R6 and R7 may be linked to form a heterocyclic group, or where R5, R6 and R7 are in a (CONR5NR6R7) group, R5 and R6 may be linked to form a heterocyclic group; and R8 is selected from alkyl and aryl, or a pharmaceutically acceptable salt thereof or prodrug thereof, in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, particularly wherein sType: ApplicationFiled: January 12, 2006Publication date: May 25, 2006Inventors: Roger Gillespie, Joanne Lerpiniere, Suneel Gaur
-
Publication number: 20060081198Abstract: A water heater including a water container; a combustion chamber adjacent the water container; a burner associated with the combustion chamber; a blower assembly located to receive combustion products generated by the burner; an intake conduit sealingly connected to the combustion chamber and having a combustion air intake opening located adjacent an upper portion of the water heater; and a dilution air conduit sealingly connected to the blower assembly and having a dilution air intake opening located adjacent a lower portion of the water heater.Type: ApplicationFiled: October 20, 2004Publication date: April 20, 2006Applicant: American Water Heater Company, a corporation of NevadaInventors: Michael Garrabrant, James York, Jeff Lyons, Tim Smith, Roger Gillespie
-
Publication number: 20050143436Abstract: The present invention relates to novel classes of compounds which are inhibitors of interleukin-1? converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-?-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-?-mediated diseases and decreasing IGIF and IFN-? production using the compounds and compositions of this invention.Type: ApplicationFiled: November 29, 2004Publication date: June 30, 2005Inventors: Mark Batchelor, David Bebbington, Guy Bemis, Wolf Fridman, Roger Gillespie, Julian Golec, David Lauffer, David Livingston, Saroop Matharu, Michael Mullican, Mark Murcko, Robert Murdoch, Robert Zelle
-
Patent number: D828016Type: GrantFiled: September 16, 2016Date of Patent: September 11, 2018Assignee: M-PAKS LLCInventors: Kirk Stanley Gillespie, Kevin Roger Gillespie, Sean Miller